baber/WOPTO huggingface dataset:
Patent NZ-575188-A (NZ)
Title: Novel anti-cd38 antibodies for the treatment of cancer
Inventor: PARK PETER U
IPC: C07K16/46
Filed: 2007-10-16
Abstract: Antibodies, humanized antibodies, resurfaced antibodies, antibody fragments, derivatized antibodies, and conjugates of same with cytotoxic agents, which specifically bind to CD38, are capable of killing CD38+ cells by apoptosis, antibody-dependent cell-mediated cytotoxicity (ADCC), and/or complement-dependent cytotoxicity (CDC). Said antibodies and fragments thereof may be used in the treatment of tumors that express CD38 protein, such as multiple myeloma, chronic lymphocytic leukemia, chronic myelogenous leukemia, acute myelogenous leukemia, or acute lymphocytic leukemia, or the treatment of autoimmune and inflammatory diseases such as systemic lupus, rheumatoid arthritis, multiple sclerosis, erythematosus, and asthma. Said derivatized antibodies may be used in the diagnosis and imaging of tumors that express elevated levels of CD38. Also provided are cytotoxic conjugates comprising a cell binding agent and a cytotoxic agent, therapeutic compositions comprising the conjugate, methods for using the conjugates in the inhibition of cell growth and the treatment of disease, and a kit comprising the cytotoxic conjugate. In particular, the cell binding agent is a monoclonal antibody, and epitope-binding fragments thereof, that recognizes and binds the CD38 protein.
Patent NZ-578286-A (NZ)
Title: Apparatus for making variable diameter holes in metal plates
Inventor: COLOMBO CHRISTIAN
IPC: B23B39/06
Filed: 2009-07-09
Abstract: An apparatus for making variable diameter and shape holes through metal plates in a sheet plate machining gantry machine comprises two parallel cross members (11) and two horizontal parallel guides (10) integral with the cross members and supporting horizontal cross arm (4) which is controllably driven on the guides. The horizontal arm supporting the horizontal parallel guides therealong is controllably driven an apparatus including a milling tool (2) which can controllably driven in a vertical plane. The method comprises the step of controllably simultaneously driving a two-fluted mill (2) both in a vertical plane (Z), and in a horizontal plane (U).
Patent NZ-591339-A (NZ)
Title: Vertical shaft impact crusher, feeding chamber side wall and method for replacing a worn feed tube
Inventor: KJAERRAN KNUT
IPC: A47J43/07
Filed: 2009-10-01
Abstract: 591339 A vertical shaft impact crusher with a rotor which rotates about a vertical axis for accelerating a flow of material to be crushed. The crusher has a housing with a circumferential impact wall section against which the accelerated flow of material is crushed. The crushing includes a feed tube which vertically feeds a flow of material into the rotor. The crusher has a feeding chamber with a side wall which vertically feeds a flow of material into the feed tube. The feeding chamber side wall has a first door for opening and closing a first aperture. The feed tube is removable from the feeding chamber via the first aperture.
Patent NZ-595910-A (NZ)
Title: Carbinol compound having heterocyclic linker
Inventor: KUROBUCHI SAYAKA
IPC: A61K31/4164
Filed: 2010-04-28
Abstract: 595910 Disclosed herein is a carbinol compound of the general formula (I), wherein the variables are defined in the specification, and the use thereof as an LXR regulator for use in the treatment of atherosclerosis, arteriosclerosis, dyslipidemia, hypercholesterolemia, lipid-related diseases, inflammatory diseases that are caused by inflammatory cytokines, skin diseases, diabetes, or Alzheimer's disease. Embodiments of the carbinol compound include: (2S,5R)-5-(2,3-dihydrofuro[2,3-c]pyridin-5-yl)-3-(2-(4-(4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)-2-propylphenyl)-2,5-dimethylpiperazin-1-yl)-2-oxoethyl)-5-methylimidazolidine-2,4-dione, (2S,5R,Z)-3-[2-(4-{ 4-[2-(benzyloxy)-1,1,1,3,3,3-hexafluoropropan-2-yl]-2-(prop-1-en-1-yl)phenyl} -2,S-dimethylpiperazin-1-yl)-2-oxoethyl]-S-(2,3-dihydrobenzo[b][1,4]dioxin -6-yl)-S-methylimidazolidine-2,4-dione, and 3-[2-(4-{ 4-[2-(benzyloxy)-1,1,1,3,3,3-hexafluoropropan-2-yl]-2-(prop-1-en-1-yl)phenyl} piperazin-1-yl)-2-oxoethyl]-5-(2,3-dihydro-[1,4]dioxino[2,3-b]pyridin-7-yl)-5-methylimidazolidine-2,4-dione.
Patent NZ-598397-A (NZ)
Title: A package for tobacco products
Inventor: BRAY ANDREW JONATHAN
IPC: B65D85/10
Filed: 2010-08-17
Abstract: A soft cup package 1 for tobacco products comprises a cup-shaped outer container 2 having an open face 26, and an inner enclosure 4 located in the outer container 2 and configured to surround the tobacco products. A moveable cover 6 is connected to a first side 22 of the outer container. The package further comprises an adhesive arranged to releasably secure the cover6 to a second side 20 of the outer container with the cover 6 extending over the open face. The cover 6 extends across the majority of the width of the open face 26. The outer container 2 and cover 6 is formed by at least two parts fixed together.
Patent NZ-598618-A (NZ)
Title: Pharmaceutical combination for treating tumor
Inventor: UENO RYUJI
IPC: A61P35/00
Filed: 2010-09-16
Abstract: Disclosed herein is a pharmaceutical combination comprising: (a) a pharmaceutically effective amount of an anti–tumor agent selected from the group consisting of cyclophosphamide, buslfan, methotrexate, 6-mercaptopurine (6-MP), azathioprine, fluorouracil (5-FU), tegafur, cytosine arabinoside (ara-C), bleomycin, mitomycin C, daunorubicin, adriamycin, actinomycin D, vincristine, vinblastine, vindesine, paclitaxel, docetaxel, etoposide, irinotecan, imatinib, gefinitib, erlotinib, sorafenib, sunitinib, trastuzumab, rituximab, gemtuzumab-ozogamicin, bevacizumab, cetuximab, prednisolone, diethylstilbestrol, tamoxifen, cisplatin, carboplatin, oxaliplatin, bcl-2 antisense, hsp27 antisense, XIAP antisense, PKC-alpha antisense, hypoxia-induced factor antisense, CD20 antibody, Her2 antibody, VEGF antibody, EGFR antibody and RNAi targeted Ribonucleotide reductase, and (b) a pharmaceutically effective amount of a fatty acid derivative represented by the formula (I), wherein the substituents are as defined within the specification. Also disclosed is the use of a fatty acid derivative of formula I in the manufacture of a medicament for the treatment of mucositis.
Patent NZ-599037-A (NZ)
Title: Condensed milk-like whey compositions and process for preparing it
Inventor: ICHIBA MIKIHIKO
IPC: A23C21/08
Filed: 2010-08-30
Abstract: NZ 599037 Disclosed is a whey-containing condensed milk composition which is obtained by carrying out heat sterilisation and concentration of a liquid whey formulation, wherein the liquid whey formulation is prepared by adding auxiliary materials containing sucrose to a liquid whey preliminarily heated at high temperature, wherein the preliminary heat treatment at high temperature is carried out under the temperature condition of 100 to 150 degrees Celsius for 1 to 30 seconds.
Patent NZ-600916-A (NZ)
Title: Dietary fibre composition containing beta-glucan
Inventor: DUSS RUEDI
IPC: A23L7/10
Filed: 2009-11-30
Abstract: Discloses a dietary fibre composition comprising at least one cereal grain component containing B-glucan, wherein the B-glucan has a peak molecular weight above 500 kDa, a solubility at 37°C of at least 50% of extracted B-glucan to the total B-glucan content in an extract of the fibre composition, and a viscosity of the extract at 37°C of at least 800 mPa·s measured at 30s-1.
Patent NZ-601324-A (NZ)
Title: Methods for use of a specific anti-angiogenic adenoviral agent
Inventor: SHER NAAMIT
IPC: C12N15/00
Filed: 2011-01-05
Abstract: Use of an adenovirus vector in the preparation of a medicament for treating a solid tumor, wherein said vector comprises a fas-chimera transgene transcriptionally linked to a pre-proendothelin promoter and wherein the medicament is formulated for administration of at least 3x10^12 particles of adenovirus vector to the subject.
Patent NZ-602002-A (NZ)
Title: Woodworking facility
Inventor: HUNDEGGER HANS
IPC: B27B25/00
Filed: 2012-08-23
Abstract: Disclosed is a woodworking facility to allow more accurate measurements and machining to take place. The facility includes a workpiece support (8) and a belt or chain arrangement for registering the movement of a workpiece (7) that lies on the workpiece support (8) and is transported there on in order to be processed. The belt or chain arrangement comprises a belt (1) or chain that is guided over at least two deflection pulleys (2, 3) and designed for contacting the workpiece (7). The belt or chain is pressed against the workpiece (7) normal to a surface of the belt (1) or the chain in contact with the workpiece by means of a pressing device (10) assigned to the belt (1) or the chain. The pressing device (10) comprises several pressing elements (11) linked together into an endless chain that are moved together and guided over at least two pocket wheels (12, 13) with the belt (1) or the chain in the moving direction thereof.
Patent NZ-603672-A (NZ)
Title: Process for preparing pyrimidinone compounds
Inventor: DAVIES SUZANNE HELEN
IPC: C07D239/70
Filed: 2011-05-17
Abstract: Disclosed is a process for making a thio-substituted cyclopenta[d]pyrimidine compound of formula (I). The process comprising the steps of: (a) treating a C(1-4)alkyl 2-oxocyclopentanecarboxylate with an alkali metal salt of glycine to form a compound of formula (A) (b) cyclising a compound of said formula (A) to form the hexahydro-1H-cyclopenta[d]pyrimidin-1-yl)acetic acid of formula (B) by treating a compound of said formula (A) with either: (i) a thiocyanate salt and (B) a) a haloalkylsilane and a proton source, with heating, or b) an anhydrous acid, with heating; or (ii) trimethylsilylisothiocyanate, with heating; (c) forming a thio-4-oxo-4,5,6,7-tetrahydro-lH-cyciopenta[d]pyrimidin-l-yl)acetic acid of formula (C) by treating a compound of said formula (B) with a thio-alkylating reagent which is a benzyl derivative of formula (D) (d) treating an aldehyde of formula (E) with an amine, a heavy metal catalyst and hydrogen to form a secondary amine of formula (F) (e) forming a compound of formula (I) by treating a compound of said formula (C) with carbonyldiimidazole and the secondary amine of formula (F) and heating the mixture. An example of a compound of formula (I) is: N-[2-(diethylamino)ethyl]-2-(2-{ [(4-fluorophenyl)methyl]thio} -4-oxo-4,5,6,7-tetrahydro-1H-cyciopenta[d]pyrimidin-1-yl)-N-{ [4’-(trifluoromethyl)-4-biphenylyl]methyl} acetamide.
Patent NZ-604073-A (NZ)
Title: Needle shield for a safety device, safety device and injection device
Inventor: ROBERTS GARETH
IPC: A61M5/32
Filed: 2011-06-21
Abstract: 604073 A needle shield (1.1) comprising at least two different plastic materials of different flexibility and a central aperture (1.1.3) of variable diameter. The central aperture comprises a first diameter (D1) for retaining a needle cap (2.2) therein. The diameter of the central aperture changes upon removal of the needle cap from the first diameter to a second diameter (D2) by virtue of a memory effect of the material of the needle shield. At least one of the plastic materials has a shape memory. The needle shield is made by a two-shot injection moulding process.
Patent NZ-613087-A (NZ)
Title: Histone deacetylase inhibitors and compositions and methods of use thereof
Inventor: LUCKHURST CHRISTOPHER A
IPC: A61K31/19
Filed: 2012-01-23
Abstract: The disclosure relates to substituted phenylcyclopropanecarboxamide derivatives of formula (I) and pharmaceutically acceptable salt thereof, which are histone deacetylase (HDAC) inhibitors, wherein the variables are as defined in the specification. These compounds of formula (I) are suitable for treating a condition or disorder mediated by at least one histone deacetylase in a subject, and therefore useful for treating a neurodegenerative pathology, particularly Huntington’s disease.
Patent NZ-615578-A (NZ)
Title: Pyridopyrazine derivatives and their use
Inventor: GERLACH MATTHIAS
IPC: C07D471/04
Filed: 2012-04-04
Abstract: Disclosed herein are pyridopyrazine compounds of formula where the substituents are as defined herein, for example 1-[3-(2-methoxy-phenyl)-pyrido[2,3-b]pyrazin-6-yl]-3-(4-phenyl-butyl)-urea and 1-[3-(4-{ 2-[2-(2-hydroxy-ethoxy)-ethoxy]-ethoxy} -phenyl)-pyrido[2,3-b]pyrazin-6-yl]-3-(4-phenyl-butyl)-urea. The compounds are suitable for the treatment or prevention of physiological and/or pathophysiological states in mammals mediated by the ras-Raf-Mek-Erk signal transduction pathway including cancer, HIV and cardiovascular diseases.
Patent NZ-624126-A (NZ)
Title: Solid state light
Inventor: PATRICK JOHN MARTIN
IPC: H01L33/00
Filed: 2014-04-24
Abstract: A solid state light (1) in the form of a tube that may be used to retrofit to existing fluorescent light fittings is disclosed. The light has a substantially tubular shape includes a solid transparent rod (2) of semi-circular to circular cross-section having a central longitudinal axis and being made of a material that sustains total internal reflection of light. A reflector (6) is attached to reflect light from the rod, wherein the reflector is a diffusely reflective strip extending along the rod at or near the surface thereof. A plurality of radial bores (5) spaced apart along the length of the rod contain powered LED light sources (3). The LEDs are disposed back to back so that light emitted from each LED is directed generally parallel to the central longitudinal axis of the body and generally normal to the axis of the bores. An electric circuit coupling the plurality of LED lights to at least one end connection (8) of the tube is provided so that the end connection is able to electrically couple with an existing fluorescent tube fitting. An opaque backing (4) is aligned behind or about the reflector.
Patent NZ-628583-A (NZ)
Title: 6 - alkynyl pyridines as smac mimetics
Inventor: REISER ULRICH
IPC: C07D417/06
Filed: 2013-02-25
Abstract: Disclosed are 6-alkynyl-pyridine compounds of general formula (I), wherein the substituents are as defined in the specification. The compounds are SMAC mimetics, useful for the treatment and/or prevention of diseases characterized by excessive or abnormal cell proliferation and associated conditions such as cancer. Examples of a compound of formula (I) are: 3-[6-(2-aminopropanoylamino)-2-(2-phenylethynyl)pyridin-3-yl]-benzoic acid 2-(methylamino)-N- [5-(2-methylimidazo[1,2-a] pyridin-3-yl)-6- [2-(1-methyl-2-oxoquinolin-6-yl)ethynyl] pyridin-2-yl] propanamide N-methyl-N-[6-[2-(methylamino )propanoylamino ]-2-(2-phenylethynyl)pyridin-3-yl] oxane-4-carboxamide
Patent NZ-629902-A (NZ)
Title: Process and plant for producing a solid product
Inventor: AUNBIRK NIELS
IPC: F28C3/10
Filed: 2012-03-07
Abstract: A process for separating of a minced, chopped, crushed or mashed food slurry into solid and liquid components after the application of steam for heat treatment. The process extracts the condensed steam water absorbed by the slurry. The process includes: a. heating by direct steam injection the finely divided slurry, b. separating the heated slurry into a solid product and an aqueous liquid, c. heating and pressurizing the aqueous liquid, and d. reducing the pressure of the aqueous liquid thereby generating steam and the liquid product, wherein the steam generated in step d is returned to step a for injection into the slurry.
Patent NZ-700778-A (NZ)
Title: Crystalline forms of 3-(2,6-dichloro-3,5-dimethoxy-phenyl)-1-{ 6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl} -1-methyl-urea and salts thereof.
Inventor: KAPA PRASAD KOTESWARA
IPC: C07D295/135
Filed: 2010-12-06
Abstract: Disclosed herein is the hydrochloride salt of 3-(2,6-dichloro-3,5-dimethoxy-phenyl)-1-{ 6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl} -1-methyl-urea (formula I). Also disclosed is the use of this compound as a kinase inhibitor for the treatment of carcinomas.
Patent NZ-707478-A (NZ)
Title: Lid with integrated container
Inventor: BUCK RONALD MARK
IPC: B65D51/28
Filed: 2012-09-06
Abstract: Disclosed is a cup lid with an integrated container that keeps one liquid separate from a second liquid in a cup. The cup lid with integrated container comprises a lid container with a lid and a container to store a first solid or a liquid separate from a second solid or liquid stored in a cup. The cup has an annular opening that lies in a plane on top of the cup and the container has a substantially flat bottom. The lid encloses the second solid or liquid within the cup. A first coupling element couples the lid to the annular opening on top of the cup; and a second coupling element couples the container to the lid. The lid and the container enable access of the first solid or liquid and the second solid or liquid without disengagement of the first coupling element from the cup and without disengagement of the second coupling element from the lid. The lid has a hole to enable access of the second solid or liquid stored in the cup at an outer portion of the lid proximal to an outer wall of the cup wherein the hole is not located within the container where the first solid or liquid is stored and wherein the hole is at or above the annular opening that lies in the plane on top of the cup and wherein a bottommost portion of the hole in the lid lies above the first coupling element and wherein a topmost portion of the hole lies beneath the second coupling element. A cover is coupled with the container and encloses the container and the cover can have a centrally located hole configured to enable access of contents of the container with a utensil.
Patent NZ-724740-A (NZ)
Title: Treatment of nafld and nash
Inventor: MCWHERTER CHARLES
IPC: A61P1/16
Filed: 2015-04-10
Abstract: Non-alcoholic fatty liver disease and non-alcoholic steatohepatitis may be treated by the administration of (R)-2-(4-((2-ethoxy-3-(4-(trifluoromethyl)phenoxy)propyl)thio)-2-methylphenoxy)acetic acid and its salts.
Patent NZ-726913-A (NZ)
Title: Data network for monitoring animals
Inventor: AUER WOLFGANG
IPC: A01K11/00
Filed: 2015-06-05
Abstract: The invention relates to a data network for automatically monitoring voluntary behaviors of individual animals of an animal herd. The individual animals (1) of the animal herd each have a node (3) of the data network. A further node (8) is attached at a location which an animal (1) preferably approaches in the course of a behavior to be monitored. In the event that the animal (1) approaches the node (8), communication occurs between the nodes (3, 8), in which communication one node is identified by the other node and a central data-processing system is informed that the two nodes (3, 8) have come into contact. The communication between the two nodes (3, 8) occurs by means of the transfer of electrical signals in a closed electrical alternating-current circuit, which also passes, among other things, through the body of the animal (1) as an electrical conductor.
Patent NZ-729829-A (NZ)
Title: Novel cryopreservation bags and method of use thereof for closed system, high capacity cell-banking
Inventor: COUPIER HERVÉ
IPC: A61J1/10
Filed: 2015-08-14
Abstract: The disclosure provides a cell freezing and storage bag assembly and a method for using the assembly in banking eukaryotic cells for later seed train expansion. The bag (1) is constructed principally of fluorinated ethylene propylene (FEP) fabric. The bag design includes at least an inlet conduit (2) and an outlet or inoculation conduit (3), which can be sterilely welded to the source of the cells, allowing for “closed system” filling of the bags, which significantly reduces the risk of contamination. The bag also includes a sleeve (8), which can be thermosealed (”S”) to form an enclosure, which protects the inlet and outlet conduits against contamination and mechanical damage during freezing, storage and subsequent thawing. In the method, once each bag is filled, its corresponding inlet conduit is sealed (”AS”), and both the inlet and outlet conduits are enclosed within the sleeve. This closed system method obviates the need for sterile environments.
Patent NZ-733462-A (NZ)
Title: Antibodies to tau and uses thereof
Inventor: LU JIRONG
IPC: A61P25/28
Filed: 2016-02-18
Abstract: Monoclonal antibodies to human tau aggregate, compositions comprising such tau antibodies, and methods of using such tau antibodies for the treatment of neurodegenerative diseases including Alzheimer-s disease, Progressive Supranuclear Palsy and Pick-s disease.
Patent NZ-736186-A (NZ)
Title: Transmitting positioning reference signals
Inventor: BLANKENSHIP YUFEI
IPC: H04W64/00
Filed: 2016-03-31
Abstract: Systems and methods are disclosed herein that relate wireless device positioning based on cell portion specific Positioning Reference Signals (PRSs) by multiple Transmit Points (TPs) in a shared cell. In some embodiments, a method of operation of a TP in a cellular communications network is provided. The TP is one of multiple of non-co-located TPs of a shared cell that has a shared cell identifier. The method of operation of the TP comprises transmitting a PRS having at least one parameter that is a function of a cell portion identifier of the TP, where the at least one parameter comprises a frequency-shift of the PRS, a portion of a system bandwidth in which the PRS is transmitted, and/or a PRS sequence used for the PRS. By transmitting cell-portion-specific PRSs, the TPs in the shared cell enable wireless device positioning based on PRSs transmitted by the non-co-located TPs.
Patent PT-103641-A (PT)
Title: Argamassas próprias para isolamentos térmicos e acústicos, com cal aérea hidrófugada ou não, com cortiça incorporada
Inventor: CARTAXO FERNANDO RAIMUNDO SIMOES
IPC: C04B28/22
Filed: 2007-01-22
Abstract: ARGAMASSAS DESTINADAS À EXECUÇÃO DE ISOLAMENTOS, REVESTIMENTOS OU ENCHIMENTOS NOS QUAIS A LEVEZA, DESEMPENHO ACÚSTICO OU TÉRMICO SEJAM ESSENCIAIS; ESTAS ARGAMASSAS SÃO PRODUZIDAS COM CAL AÉREA HIDROFUGADA OU NÃO, POZOLANAS NATURAIS E ARTIFICIAIS, CORTIÇA E AGREGADOS DIVERSOS; DEPOIS DE AMASSADAS, PODEM SER UTILIZADAS, POR APLICAÇÃO DIRECTA OU PROJECÇÃO, PRÉ-MOLDADAS EM FORMA DE PLACAS, TIJOLOS, BLOCOS, REBORDOS, ACESSÓRIOS DECORATIVOS OU TÉCNICOS DE FORMATO ADEQUADO, COM APLICAÇÃO SIMULTÂNEA OU ISOLADA. O INVENTO INCLUI ONZE ARGAMASSAS PRÉ-MISTURADAS E ESPECÍFICAS, (COLUNAS HORIZONTAIS DA FIGURA), UNITARIAMENTE ACONDICIONADAS NUM CONTENTOR NO MÁXIMO COM QUATRO SACOS BEM IDENTIFICADOS, HERMETICAMENTE FECHADOS, CONTENDO CADA UM DELES UM OU MAIS COMPONENTES. OS COMPONENTES DAS MISTURAS (1,2,3,4,6) PODEM SER MISTURADOS E AMASSADOS NO LOCAL DA OBRA; AS MISTURAS (5,7,8,9,10,11), ADEQUADAS PARA PRÉ-MOLDADOS, SÃO PROCESSADAS EM FÁBRICA PERMITINDO, TAMBÉM, MOLDAGEM DE PEÇAS DE MOBILIÁRIO URBANO, PAISAGÍSTICO, PROTECÇÃO SONORA RODOVIÁRIA, DISSIPADORES DE ENERGIA DE IMPACTO, OU OUTRAS CONFIGURAÇÕES GEOMÉTRICAS DIVERSIFICADAS.
Patent PT-104279-A (PT)
Title: Dispositivo de ligação de tubagens para sifão
Inventor: CIMOLAI STEPHANE
IPC: F16L43/00
Filed: 2008-12-04
Abstract: DISPOSITIVO DE LIGAÇÃO PARA TUBAGEM FÊMEA (2) PREPARADA PARA RECEBER UMA TUBAGEM MACHO (4), TENDO A REFERIDA TUBAGEM FÊMEA NA SUA EXTREMIDADE (11) UMA JUNTA (3) EM MATERIAL PLÁSTICO FLEXÍVEL QUE SE ESTENDE A PARTIR DESSA EXTREMIDADE E PODE ASSUMIR A FORMA DE UM V NO INTERIOR DA DITA TUBAGEM FÊMEA E SER COMPRIMIDA RADIALMENTE POR ACÇÃO DA INTRODUÇÃO DA TUBAGEM MACHO (4), DE MODO A GARANTIR A ESTANQUIDADE DA LIGAÇÃO; ESTE DISPOSITIVO CARACTERIZA-SE PELO FACTO DE COMPORTAR AINDA UM CASQUILHO (5) NO QUAL PODE DESLIZAR LIVREMENTE A TUBAGEM MACHO, O QUAL ESTÁ PREPARADO PARA SE FIXAR NA TUBAGEM FÊMEA E COOPERAR A NÍVEL DE UMA FACE DE APOIO (10) COM A PONTA EM V DA JUNTA, POR FORMA A ASSEGURAR A SUA RETENÇÃO EM TRANSLAÇÃO EM CASO DE TENTATIVA DE ARRANCAMENTO DA TUBAGEM MACHO (4) DO INTERIOR DA TUBAGEM FÊMEA (2).